Global Glyburide Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Glyburide Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Glyburide is a second generation sulfonylurea used to treat patients with diabetes mellitus type II. It is typically given to patients who cannot be managed with the standard first line therapy, metformin. Glyburide stimulates insulin secretion through the closure of ATP-sensitive potassium channels on beta cells, raising intracellular potassium and calcium ion concentrations.
Glyburide report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Glyburide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pediatric Use and Geriatric Use are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Glyburide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Glyburide key manufacturers include Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine, Double Whale Pharmaceutical, Bohai Pharmaceutical, Sunlight Pharmaceutical, Shapuaisi Pharma, CR Sanjiu and Physicians Total Care, etc. Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine are top 3 players and held % sales share in total in 2022.
Glyburide can be divided into 1.25mg, 2.5mg and 5mg,, etc. 1.25mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Glyburide is widely used in various fields, such as Pediatric Use, Geriatric Use and Others,, etc. Pediatric Use provides greatest supports to the Glyburide industry development. In 2022, global % sales of Glyburide went into Pediatric Use filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glyburide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Amneal Pharmaceuticals
Sanofi Aventis
Jisheng Medicine
Double Whale Pharmaceutical
Bohai Pharmaceutical
Sunlight Pharmaceutical
Shapuaisi Pharma
CR Sanjiu
Physicians Total Care
Hoechst Canada
Apotex Corporation
Avanstra
Dominion Pharmacal
Hikma Pharmaceuticals
Cadila Pharmaceuticals
Novartis
Segment by Type
1.25mg
2.5mg
5mg
Pediatric Use
Geriatric Use
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Glyburide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Glyburide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Glyburide industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Glyburide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Glyburide introduction, etc. Glyburide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Glyburide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Glyburide report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Glyburide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pediatric Use and Geriatric Use are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Glyburide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Glyburide key manufacturers include Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine, Double Whale Pharmaceutical, Bohai Pharmaceutical, Sunlight Pharmaceutical, Shapuaisi Pharma, CR Sanjiu and Physicians Total Care, etc. Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine are top 3 players and held % sales share in total in 2022.
Glyburide can be divided into 1.25mg, 2.5mg and 5mg,, etc. 1.25mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Glyburide is widely used in various fields, such as Pediatric Use, Geriatric Use and Others,, etc. Pediatric Use provides greatest supports to the Glyburide industry development. In 2022, global % sales of Glyburide went into Pediatric Use filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glyburide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Amneal Pharmaceuticals
Sanofi Aventis
Jisheng Medicine
Double Whale Pharmaceutical
Bohai Pharmaceutical
Sunlight Pharmaceutical
Shapuaisi Pharma
CR Sanjiu
Physicians Total Care
Hoechst Canada
Apotex Corporation
Avanstra
Dominion Pharmacal
Hikma Pharmaceuticals
Cadila Pharmaceuticals
Novartis
Segment by Type
1.25mg
2.5mg
5mg
Segment by Application
Pediatric Use
Geriatric Use
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Glyburide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Glyburide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Glyburide industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Glyburide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Glyburide introduction, etc. Glyburide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Glyburide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.